PHILADELPHIA, March 20, 2012 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company"), has scheduled a conference call and audio webcast on Thursday, March 22, 2012 at 10:00 a.m. (Eastern Time). The conference call will discuss its year-end 2011 results of operations and will also focus on the Company's Chronic Fatigue Syndrome program as well as advances at the New Brunswick manufacturing facility.
